Research Progress of Related Assessment Tools for Patient Medication Experience

doi:10.12114/j.issn.1007-9572.2019.00.262

Abstract

Abstract: The medication experience of patients has much influence on their belief in taking medicine，behaviors and disease outcomes，while there are currently many kinds of assessment tools for patient medication experience that have not been unified.Therefore，this paper sorts out the related concepts of patient medication experience and the development process，content，reliability and validity，advantages and disadvantages of these assessment tools，in order to provide a scientific reference for the rational evaluation of patient medication experience.

Key words: Drug therapy, Medication experience, Assessment tools, Review

摘要：

患者用药体验对其服药信念、行为和疾病转归等产生重大影响，但目前关于患者用药体验测评工具种类较多，且尚未统一，因此本文就患者用药体验相关概念及其用药体验相关测评工具的发展过程、内容、信效度、优缺点进行梳理，以期为合理评估患者用药体验提供科学参考。

关键词: 药物疗法, 用药体验, 测评工具, 综述

WANG Yongli,GUO Yawen,FU Bo, et al. Research Progress of Related Assessment Tools for Patient Medication Experience　[J]. Chinese General Practice, 2020, 23(2): 125-129. DOI: 10.12114/j.issn.1007-9572.2019.00.262.
王永利,郭亚雯,符博等. 患者用药体验相关测评工具的研究进展[J]. 中国全科医学, 2020, 23(2): 125-129. DOI: 10.12114/j.issn.1007-9572.2019.00.262.

References

［1］陈建，杨晓虹，曾莉萍，等．成都新都区社区居民老年慢性病患病现状及其患共病模式分析［J］．中国卫生事业管理，2018，35（8）：573-575，615.
［2］GUTHRIE B，MAKUBATE B，HERNANDEZ-SANTIAGO V，et al．The rising tide of polypharmacy and drug-drug interactions：population database analysis 1995—2010［J］．BMC Med，2015，13：74．DOI：10.1186/s12916-015-0322-7.
［3］UK N M A P.Medicines optimisation：the safe and effective use of medicines to enable the best possible outcomes［M］．Manchester：National Institute for Health and Care Excellence （UK），2015.
［4］YOUSSEF A.Pharmaceutical care practice：the clinician's guide［J］．Int J Toxicol，2004，23（6）：379-380．DOI：10.1080/10915810490902074.
［5］ETON D T，RIDGEWAY J L，EGGINTON J S，et al．Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions［J］．Patient Relat Outcome Meas，2015，6：117-126．DOI：10.2147/PROM.S78955.
［6］SAV A，SALEHI A，MAIR F S，et al．Measuring the burden of treatment for chronic disease：implications of a scoping review of the literature［J］．BMC Med Res Methodol，2017，17（1）：140．DOI：10.1186/s12874-017-0411-8.
［7］BOYCE M B，BROWNE J P，GREENHALGH J.The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare：a systematic review of qualitative research［J］．BMJ Qual Saf，2014，23（6）：508-518．DOI：10.1136/bmjqs-2013-002524.
［8］MOHAMMED M A，MOLES R J，CHEN T F.Medication-related burden and patients' lived experience with medicine：a systematic review and metasynthesis of qualitative studies［J］．BMJ Open，2016，6（2）：e010035．DOI：10.1136/bmjopen-2015-010035.
［9］ATKINSON M J，SINHA A，HASS S L，et al．Validation of a general measure of treatment satisfaction，the Treatment Satisfaction Questionnaire for Medication （TSQM），using a national panel study of chronic disease［J］．Health Qual Life Outcomes，2004，2：12．DOI：10.1186/1477-7525-2-12.
［10］ATKINSON M J，KUMAR R，CAPPELLERI J C，et al．Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication （TSQM versionⅡ） among outpatient pharmacy consumers［J］．Value Health，2005，8（Suppl 1）：S9-24．DOI：10.1111/j.1524-4733.2005.00066.x.
［11］BHARMAL M，PAYNE K，ATKINSON M J，et al．Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication （TSQM-9） among patients on antihypertensive medications［J］．Health Qual Life Outcomes，2009，7：36．DOI：10.1186/1477-7525-7-36.
［12］ZANICHELLI A，AZIN G M，CRISTINA F，et al．Safety，effectiveness，and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor （Berinert?） in patients with hereditary angioedema：the SABHA study［J］．Orphanet J Rare Dis，2018，13（1）：51．DOI：10.1186/s13023-018-0797-3.
［13］尚雅彬，刘红霞，于立新，等．药物治疗满意度量表的跨文化调试及其在肾移植受者中应用的信度效度检验［J］．中国护理管理，2018，18（5）：612-616．DOI：10.3969/j.issn.1672-1756.2018.05.008.
［14］VAN DEN BOSCH F，OSTOR A J K，WASSENBERG S，et al．
Impact of participation in the adalimumab （humira） patient support program on rheumatoid arthritis treatment course：results from the PASSION study［J］．Rheumatol Ther，2017，4（1）：85-96．DOI：10.1007/s40744-017-0061-7.
［15］ZYOUD S H，AL-JABI S W，SWEILEH W M，et al．Relationship of treatment satisfaction to health-related quality of life among Palestinian patients with type 2 diabetes mellitus：findings from a cross-sectional study［J］．J Clin Transl Endocrinol，2015，2（2）：66-71．DOI：10.1016/j.jcte.2015.03.002.
［16］RUIZ M A，PARDO A，REJAS J，et al．Development and validation of the “Treatment Satisfaction with Medicines Questionnaire” （SATMED-Q）［J］．Value Health，2008，11（5）：913-926．DOI：10.1111/j.1524-4733.2008.00323.x.
［17］REJAS J，RUIZ M，PARDO A，et al．Detecting changes in patient treatment satisfaction with medicines：the SATMED-Q［J］．Value Health，2013，16（1）：88-96．DOI：10.1016/j.jval.2012.08.2224.
［18］QUINLAN P，MAGID S K，O’FLAHERTY D，et al．Patient satisfaction with medication management［J］．J Nurs Care Qual，2007，22（1）：34-39．DOI：10.1097/00001786-200701000-00008.
［19］HORNE R，HANKINS M，JENKINS R.The Satisfaction with Information about Medicines Scale （SIMS）：a new measurement tool for audit and research［J］．Qual Health Care，2001，10（3）：135-140.
［20］BOONS C C L M，TIMMERS L，VAN SCHOOR N M，et al．Patient satisfaction with information on oral anticancer agent use［J］．Cancer Med，2018，7（1）：219-228．DOI：10.1002/cam4.1239.
［21］NOTA I，DROSSAERT C H，TAAL E，et al．Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs［J］．Arthritis Res Ther，2016，18（1）：252．DOI：10.1186/s13075-016-1138-3.
［22］DREVENHORN E，BENGTSON A，NYBERG P，et al．Effects on hypertensive patients' satisfaction with information about their medication after nurses' consultation training［J］．Pragmat Obs Res，2011，5：35-41．DOI：10.2147/POR.S58352.
［23］BOONS C C L M，TIMMERS L，VAN SCHOOR N M，et al．Patient satisfaction with information on oral anticancer agent use［J］．Cancer Med，2018，7（1）：219-228．DOI：10.1002/cam4.1239.
［24］KRSKA J，MORECROFT C W，ROWE P H，et al．Measuring the impact of long-term medicines use from the patient perspective［J］．Int J Clin Pharm，2014，36（4）：675-678．DOI：10.1007/s11096-014-9970-5.
［25］KRSKA J，KATUSIIME B，CORLETT S A.Validation of an instrument to measure patients' experiences of medicine use：the Living with Medicines Questionnaire［J］．Patient Prefer Adherence，2017，11：671-679．DOI：10.2147/PPA.S126647.
［26］KATUSIIME B，CORLETT S A，KRSKA J.Development and validation of a revised instrument to measure burden of long-term medicines use：the Living with Medicines Questionnaire version 3［J］．Patient Relat Outcome Meas，2018，9：155-168．DOI：10.2147/PROM.S151143.
［27］ZIDAN A，AWAISU A，HASAN S，et al．The living with medicines questionnaire：translation and cultural adaptation into the Arabic context［J］．Value Health Reg Issues，2016，10：36-40．DOI：10.1016/j.vhri.2016.07.001.
［28］CARTER S R，BULANADI M G，KATUSIIME B，et al．Comprehensibly measuring patients' subjective thoughts，feelings and experiences of living with medicines：the Living with Medicines Questionnaire （LMQ）［J］．Int J Clin Pharm，2015，37（2）：424-425.
［29］MOHAMMED M A，MOLES R J，HILMER S N，et al．Development and validation of an instrument for measuring the burden of medicine on functioning and well-being：the Medication-Related Burden Quality of Life （MRB-QoL） tool［J］．BMJ Open，2018，8（1）：e018880．DOI：10.1136/bmjopen-2017-018880.
［30］SAKTHONG P，SUKSANGA P，SAKULBUMRUNGSIL R，et al．Development of Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life （PROMPT-QoL）：a novel instrument for medication management［J］．Res Social Adm Pharm，2015，11（3）：315-338．DOI：10.1016/j.sapharm.2014.10.002.
［31］REEVE E，SHAKIB S，HENDRIX I，et al．Development and validation of the Patients' Attitudes Towards Deprescribing （PATD） questionnaire［J］．Int J Clin Pharm，2013，35（1）：51-56．DOI：10.1007/s11096-012-9704-5.
［32］REEVE E，LOW L F，SHAKIB S，et al．Development and validation of the revised Patients' Attitudes Towards Deprescribing （rPATD） questionnaire：versions for older adults and caregivers［J］．Drugs Aging，2016，33（12）：913-928．DOI：10.1007/s40266-016-0410-1.
［33］吴慧利.老年住院糖尿病患者潜在不恰当用药现状及停药态度问卷的适用性研究［D］．郑州：郑州大学，2017.
［34］SCHI?TZ M L，FR?LICH A，JENSEN A K，et al．Polypharmacy and medication deprescribing：a survey among multimorbid older adults in Denmark［J］．Pharmacol Res Perspect，2018，6（6）：e00431．DOI：10.1002/prp2.431.

[1]	ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752.
[2]	WEN Yongxia, SUN Hai, CHEN Xiaoju, CAI Wanjing, LI Shuni, GUO Honghua. A Systematic Review of the Assessment Tools for Maternal Psychological Birth Trauma [J]. Chinese General Practice, 2025, 28(20): 2555-2561.
[3]	GAO Min, LI Xiaona, SHI Yongli, LI Ziyuan, DONG Ping, FENG Zhiqiang, MA Dongping, YIN Wenqiang, CHEN Zhongming. Influencing Factors for Medication Experience and Medication Adherence in Elderly Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(11): 1309-1314.
[4]	YU Yuemin, MO Feifei, LI Lesi, PAN Jiyang. The Assessment Tools and Influencing Factors of Insomnia in Chinese Adolescents: a Scoping Review [J]. Chinese General Practice, 2025, 28(10): 1213-1219.
[5]	LI Chunyang, WANG Jiajia, WEI Mengyu, LI Jiansheng. Research Status of Patient-reported Outcome Measurements for Acute Exacerbation of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2024, 27(31): 3896-3904.
[6]	CHEN Muxin, LIANG Hao, ZHAO Yidi, YANG Xiaomin, FANG Jiamin, ZHOU Chunjiao, FU Xiuzhen, WEI Lin. Effectiveness Comparison of Different Frailty Assessment Tools in Preoperative Frailty Screening in the Elderly [J]. Chinese General Practice, 2024, 27(30): 3790-3796.
[7]	ZHOU Jun, LIU Xiaoyu, WANG Ping, YAN Yan, LIN Jiaming, ZHANG Kuayue, DONG Pengxuan, LIU Yuzhi, HU Xiaocong, MI Baohong, WANG Rongtian, CHEN Yuefeng, CHEN Weiheng. The Current Status of Non-surgical Treatment for Knee Osteoarthritis Patients in the Community: a Multi-center Cross-sectional Study [J]. Chinese General Practice, 2024, 27(24): 2969-2975.
[8]	Eating Disorders Coordination Group of the Psychosomatic Medicine Society of the Chinese Medical Association, Eating Disorders Research Collaboration Group of the Psychiatric Medicine Society of the Chinese Medical Association, PENG Sufang, HE Qianqian, LIU Qiang, CHEN Yan, ZHANG Lan, LI Xueni, QIAO Huifen, KONG Qingmei, KUANG Guifang, CHEN Han, YU Yang, JIANG Jingjing, LIU Lanying, ZHANG Darong, LI Keqing, WANG Zhen, CHEN Jue. Chinese Expert Consensus on the Diagnosis and Treatment of Binge Eating Disorder [J]. Chinese General Practice, 2024, 27(24): 2941-2953.
[9]	JIANG Xiaoli, PENG Haibo, XU Lingfeng, XU Na, YIN Chengliang, MENG Wenqi, LIU Songyi, YIN Wenqiang, CHEN Zhongming, MA Dongping, YU Qianqian. Effectiveness Evaluation of Contracted Residents' First Contact in Primary Care in the Context of Contracted Family Doctor Services [J]. Chinese General Practice, 2024, 27(10): 1231-1237.
[10]	WANG Qingyu, LIN Zheng, LEI Yang, SUN Caiyun, WANG Mi, GU Junyi, ZHU Zhanhui, TANG Lichen. Assessment and Treatment of Avoidant/Restrictive Food Intake Disorder in Children and Adolescents [J]. Chinese General Practice, 2024, 27(09): 1028-1033.
[11]	TAN Huiwen, LI Danting, YU Yerong. Interpretation of the 2022 ICCE/AME Position Statement for Clinical Practice in Pituitary Prolactinoma: Update on Clinical Characteristics and Points of Diagnosis and Treatment of Pituitary Prolactinoma [J]. Chinese General Practice, 2024, 27(06): 650-655.
[12]	LIU Zhigang, LIU Shimeng, ZHENG Lyuyun, XUE Wenjing, CAO Chenchen, LIU Jing, CHEN Yingyao. Second-line Medication Preference in Patients with Type 2 Diabetes: a Study Based on a Discrete Choice Experiment [J]. Chinese General Practice, 2024, 27(01): 67-73.
[13]	WEI Mengyu, WANG Jiajia, ZHANG Yingying, LI Chunyang, LI Jiansheng. Research Status of Patient-reported Outcome Assessment Tools for Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3725-3733.
[14]	WANG Xinyuan, WANG Xiaolei, LIU Yanli, AN Ran, LUO Jiao, LIU Xiaofei, LI Yangyang, HU Chongdie, HOU Fuwen. Advances in Evaluation Tools for Resistiveness to Care in Patients with Dementia [J]. Chinese General Practice, 2023, 26(22): 2816-2822.
[15]	WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan. Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease [J]. Chinese General Practice, 2023, 26(17): 2155-2161.